Kryger Capital’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Kryger Capital’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-750,571	Closed	-$99M	–	28
2025 Q1	$99M	Buy	+750,571	New	+$93.5M	11.61%	3

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Kryger Capital's ITCI Position: Q2 2025 in Review

Kryger Capital sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 750,571 shares — an estimated $99M sold.

Kryger Capital first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $99M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Kryger Capital reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Kryger Capital sold 750,571 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $99M.
Kryger Capital first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
Kryger Capital's Intra-Cellular Therapies Inc. position peaked at $99M in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Kryger Capital's 13F filing for Q2 2025, filed 6 Aug 2025.